Cargando…
Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
Experimental studies have provided strong evidence that chronic inflammation triggered by the sub-endothelial accumulation of cholesterol-rich lipoproteins in arteries is essential in the initiation and progression of atherosclerosis. Recent clinical trials highlighting the efficacy of anti-inflamma...
Autores principales: | Ait-Oufella, Hafid, Lavillegrand, Jean-Rémi, Tedgui, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064079/ https://www.ncbi.nlm.nih.gov/pubmed/33805071 http://dx.doi.org/10.3390/cells10040723 |
Ejemplares similares
-
Interleukin 5 Contributes to Human Atherosclerosis Development But not to Thrombotic Complications
por: Ait-Oufella, Hafid, et al.
Publicado: (2019) -
The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?
por: Mallat, Ziad, et al.
Publicado: (2017) -
Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling
por: Santos-Zas, Icia, et al.
Publicado: (2019) -
Narrative review: clinical assessment of peripheral tissue perfusion in septic shock
por: Hariri, Geoffroy, et al.
Publicado: (2019) -
B cell depletion reduces the development of atherosclerosis in mice
por: Ait-Oufella, Hafid, et al.
Publicado: (2010)